Noven Pharmaceuticals

Noven Pharmaceuticals is owned by Hisamitsu Pharmaceutical.

Hisamitsu Pharmaceutical is one of the...

• Topix.

Hisamitsu Pharmaceutical is a company listed under the stock ticker 4530 (JP).

Hisamitsu Pharmaceutical has a direct presence in 2 countries.

View the org chart displaying its 5 main executives

Most searched biographies at Noven Pharmaceuticals

• Naruhito Higo, Chairman of the Board and Chief Executive Officer
• Taro Ozaki, Vice Chairman, Executive Officer and Head of Productio...
• Takehito Kiuchi, Vice President, Hisamitsu Group Strategy & Planni...

Create your alert
to follow the executive moves at Noven Pharmaceuticals.

Hisamitsu Pharmaceutical has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Noven Pharmaceuticals

• Press Releases - Noven
• Press Releases - Noven

Social media about Noven Pharmaceuticals

• Noven Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Noven Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Naruhito Higo

Call Noven Pharmaceuticals at +1 305...

View the org chart

Register to receive your alert

Report an error